Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.40% |
AMGEN INC. | AMGN | 7.38% |
REGENERON PHARMACEUTICALS | REGN | 5.35% |
VERTEX PHARMACEUTICALS | VRTX | 4.42% |
MODERNA INC | MRNA | 3.73% |
GILEAD SCIENCES, INC. | GILD | 3.54% |
CORTEVA INC | CTVA | 3.40% |
ASTRAZENECA PLC ADR | AZN | 3.24% |
BIOGEN IDEC, INC. | BIIB | 3.02% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.31% |
BIOMARIN PHARMACEUTICAL | BMRN | 2.01% |
ILLUMINA INC | ILMN | 1.99% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.98% |
UNITED THERAPEUTICS CORP | UTHR | 1.92% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.92% |
SAREPTA THERAPEU | SRPT | 1.90% |
VIATRIS INC | VTRS | 1.82% |
NATERA INC | NTRA | 1.76% |
INCYTE CORP | INCY | 1.59% |
ARGENX SE - ADR | ARGX | 1.53% |
EXACT SCIENCES | EXAS | 1.50% |
REVOLUTION MEDICINES INC | RVMD | 1.37% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.36% |
CYTOKINETICS INC | CYTK | 1.34% |
BIONTECH SE-ADR | BNTX | 1.33% |
EXELIXIS, INC. | EXEL | 1.31% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.31% |
BLUEPRINT MEDICI | BPMC | 1.31% |
ALKERMES PLC | ALKS | 1.29% |
VAXCYTE INC | PCVX | 1.29% |
MEDPACE HOLDINGS | MEDP | 1.28% |
HALOZYME THERAPEUTICS INC | HALO | 1.27% |
INTRA-CELLULAR T | ITCI | 1.26% |
ROIVANT SCIENCES LTD | ROIV | 1.20% |
IONIS PHARMACEUTICALS, IN | IONS | 1.11% |
CRISPR THERAPEUTICS AG | CRSP | 1.04% |
BRIDGEBIO PHARMA INC | BBIO | 1.02% |
INSMED INC | INSM | 1.01% |
APELLIS PHARMACE | APLS | 0.90% |
AXSOME THERAPEUT | AXSM | 0.88% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.86% |
ULTRAGENYX PHARM | RARE | 0.85% |
PROTHENA CORP PL | PRTA | 0.83% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.79% |
TG THERAPEUTICS | TGTX | 0.78% |
PTC THERAPEUTICS | PTCT | 0.78% |
AMICUS THERAPEUTICS INC | FOLD | 0.77% |
GUARDANT HEALTH INC | GH | 0.76% |
INTELLIA THERAPE | NTLA | 0.72% |
IMMUNOVANT INC | IMVT | 0.68% |
DYNAVAX TECHNOLOGY | DVAX | 0.58% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.57% |
KRYSTAL BIOTECH INC | KRYS | 0.55% |
BEAM THERAPEUTICS INC | BEAM | 0.51% |
IRONWOOD PHARMAC | IRWD | 0.44% |
MADRIGAL PHARMAC | MDGL | 0.41% |
AKERO THERAPEUTICS INC | AKRO | 0.41% |
NOVAVAX INC | NVAX | 0.35% |
SAGE THERAPEUTIC | SAGE | 0.32% |
PACIFIC BIOSCIEN | PACB | 0.21% |
Other (Cash, derivatives and other liabilities) | 0.24% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.